Navigation Links
Novavax Reports Fourth Quarter and 2008 Year-End Financial Results
Date:3/31/2009

imarily to their illiquidity. Interest income for the year ended December 31, 2008 includes a $500,000 adjustment to related to the correction of the Company's accounting for the notes receivable with two former directors.

The loss from continuing operations was $10.6 million and $36.3 million for the fourth quarter and full year of 2008, respectively.

Income and losses from discontinued operations are a result of the Company's decision to discontinue manufacturing of Estrasorb. The Company recorded a loss from discontinued operations of $0.5 million in the fourth quarter of 2008 as compared to a loss of $2.8 million in the fourth quarter of 2007. The decreased loss of $2.3 million was principally due to the completion of the Graceway agreements. The Company recorded income from discontinued operations for the year ended December 31, 2008 of $0.3 million compared to a loss from discontinued operations of $6.2 million for 2007. In February 2008, the Company entered into an asset purchase agreement with Graceway, LLC providing for the sale of certain assets related to Estrasorb. The Company also entered into a supply agreement with Graceway which required the Company to manufacture additional units of Estrasorb. The Company delivered the additional units of Estrasorb and exited the facility in August 2008.

The total net loss when combining the loss from continuing and discontinued operations was $11.0 million and $36.0 million for the fourth quarter and full year of 2008, respectively.

As of December 31, 2008, the Company had $33.9 million in cash and investments (consisting of auction rate securities at their fair value) as compared to $46.5 million for the same period last year. The decrease of $12.6 million was principally due to operating losses incurred in 2008, partially offset by our equity financing of $17.5 million. Additionally, cash and short-term investments as of December 31, 2008
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
2. Novavax CEO to Present at the Partnering for Global Health Forum
3. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
4. Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
5. Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
7. Cadus Reports 2008 Results
8. Nephros Reports 2008 Fourth Quarter and Full Year Financial Results
9. Cardiogenesis Reports Fourth Quarter and Fiscal Year 2008 Results
10. Tiens Biotech Group (USA) Reports Record Twelve-Month Results
11. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... LunaDress.co.uk has updated its blog to provide professional shopping tips on ... models at LunaDress.co.uk come with big discounts, up to 80 percent ... turn out to be a most exciting memory and can show ... surprise to a wedding. On the updated fashion blog, ladies can ... a big day . , Going out with friends to a ...
(Date:12/25/2014)... (HealthDay News) -- The risk of burns from fires ... need to be extra cautious, an expert says. ... significant increase in patients coming in with burns," said ... Volunteer Firefighters Burn Center of Stony Brook University Hospital ... of joy, but if not careful, could quickly turn ...
(Date:12/25/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Among early ... treatment, less than half of one percent will eventually ... new analysis reveals. The finding comes from a ... between 1998 and 2007, and it suggests that the ... double what experts had previously thought. "The frequency ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... The AACR will present the 2011 AACR-Prevent Cancer ... Andrew J. Dannenberg, M.D., at the 10th AACR International ... 22-25, 2011. Dannenberg is director of the Weill Cornell ... York-Presbyterian/Weill Cornell Medical Center. He is also the Henry ...
... (HealthDay News) -- Although pregnant women who have high blood ... born with birth defects, new research indicates that the medications ... risk any further. The finding suggests that the widely ... enzyme (ACE) inhibitors are safe to use during the first ...
... innovative, minimally invasive ways to treat liver cancerand being ... of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for ... are reported in studies in the October Journal ... these two new studies may be beneficial to patients ...
... MD, is to receive the 2011 Morris F. Collen ... recognition of his personal commitment and dedication to informatics, ... field. Dr. Tierney, president and CEO of the Regenstrief ... of Medicine and holds the Sam Regenstrief Chair in ...
... successful initial testing of a new tool that tells ... operation is underway, so that surgeons can remove more ... survival. The report appears in ACS, journal Analytical ... that cancer can recur if tumor cells remain in ...
... assessment tool was an effective way of identifying violent hospital ... in the November issue of the Journal of Advanced ... Kim, Professor of Nursing at Point Loma Nazarene University and ... Diego, California, studied more than 2,000 patients admitted to an ...
Cached Medicine News:Health News:Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award 2Health News:Hypertension, Not Blood Pressure Drugs, Linked to Birth Defects 2Health News:Interventional radiologists: Tough on liver cancer, kind to patients 2Health News:Interventional radiologists: Tough on liver cancer, kind to patients 3Health News:Interventional radiologists: Tough on liver cancer, kind to patients 4Health News:AMIA honors Regenstrief Institute's President and CEO with 2011 Morris F. Collen Award 2Health News:AMIA honors Regenstrief Institute's President and CEO with 2011 Morris F. Collen Award 3Health News:New aggression tool predicted violent patients in medical and surgical wards 2
(Date:12/22/2014)... 2014 NxStage Medical, Inc. (NASDAQ: ... products, announced today that the U.S. Food and ... to perform hemodialysis overnight while the patient is ... NxStage,s® System One is the first and only ... indication. Home nocturnal hemodialysis is ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2Investment Analysis of the US Medical Device Sector 2
... Sept. 26, 2011 OncoSec Medical Incorporated (OTCBB: ... therapies to treat solid tumor cancers, announced today ... and Beyond: The Future of Ablation Therapies conference ... highlighted a poster titled, "OMS ElectroChemotherapy: Targeted Ablation ...
... 2011 Reportlinker.com announces that a new ... catalogue: Pharmaceutical Contract Manufacturing: ... http://www.reportlinker.com/p0629356/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical Report ... pharma contract manufacturing market perform from 2011? ...
Cached Medicine Technology:OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 2OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 3OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials 4Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 2Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 3Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 4Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 5Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 6Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 7Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 8Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 9Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 10Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 11
... The Guidant Contak Renewal 3 ... ventricular tachyarrhythmia therapy and cardiac ... right ventricular (RV) and left ... Designed to reduce irregular ventricular ...
... DAPII brain biopsy needle guide housing. ... Screw mount. Placed through a standard ... sterilize via autoclave Guide sphere assembly with ... biopsy needles with barium sleeves. Sterile; single-use ...
... Needles are available in four standard sizes. ... effective alternative to expensive, reusable brain biopsy ... Biopsy Needle Guide offers a simple yet ... as one of our biopsy needles, using ...
A complete system of cannulas, needles and rasps specifically designed for inside-out meniscal repair procedures....
Medicine Products: